Wellbutrin and Idiopathic thrombocytopenic purpura - a phase IV clinical study of FDA data

Summary:

Idiopathic thrombocytopenic purpura is found among people who take Wellbutrin, especially for people who are female, 50-59 old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Wellbutrin and have Idiopathic thrombocytopenic purpura. It is created by eHealthMe based on reports of 88,388 people who have side effects when taking Wellbutrin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jun, 30, 2022

88,388 people reported to have side effects when taking Wellbutrin.
Among them, 21 people (0.02%) have Idiopathic thrombocytopenic purpura.


What is Wellbutrin?

Wellbutrin has active ingredients of bupropion hydrochloride. It is often used in depression. eHealthMe is studying from 101,772 Wellbutrin users for its effectiveness, alternative drugs and more.

What is Idiopathic thrombocytopenic purpura?

Idiopathic thrombocytopenic purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting) is found to be associated with 1,307 drugs and 801 conditions by eHealthMe.

Number of Wellbutrin and Idiopathic thrombocytopenic purpura reports submitted per year:

Could Wellbutrin cause Idiopathic thrombocytopenic purpura?

Time on Wellbutrin when people have Idiopathic thrombocytopenic purpura *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Idiopathic thrombocytopenic purpura when taking Wellbutrin *:

  • female: 71.43 %
  • male: 28.57 %

Age of people who have Idiopathic thrombocytopenic purpura when taking Wellbutrin *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 5 %
  • 40-49: 20 %
  • 50-59: 60 %
  • 60+: 15 %

Common drugs people take besides Wellbutrin *:

  1. Betaseron: 6 people, 28.57%
  2. Detrol La: 4 people, 19.05%
  3. Zanaflex: 4 people, 19.05%
  4. Lipitor: 4 people, 19.05%
  5. Ambien: 4 people, 19.05%
  6. Gabapentin: 4 people, 19.05%
  7. Effexor Xr: 3 people, 14.29%
  8. Zantac: 3 people, 14.29%
  9. Folic Acid: 3 people, 14.29%
  10. Lexapro: 3 people, 14.29%

Common side effects people have besides Idiopathic thrombocytopenic purpura *:

  1. Headache (pain in head): 6 people, 28.57%
  2. Sleep Apnea Syndrome: 4 people, 19.05%
  3. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 19.05%
  4. Increased Tendency To Bruise (increased tendency to injure the underlying soft tissue or bone): 4 people, 19.05%
  5. Rashes (redness): 4 people, 19.05%
  6. Influenza Like Illness: 3 people, 14.29%
  7. Infusion Related Reaction: 3 people, 14.29%
  8. Hypoaesthesia (reduced sense of touch or sensation): 3 people, 14.29%
  9. Oedema Peripheral (superficial swelling): 3 people, 14.29%
  10. Head Injury: 3 people, 14.29%

Common conditions people have *:

  1. Bladder Disorder: 4 people, 19.05%
  2. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 9.52%
  3. Uveitis (inflammation of the uvea): 1 person, 4.76%
  4. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 4.76%
  5. Raynaud's Phenomenon (discoloration of the fingers, toes, and occasionally other areas): 1 person, 4.76%
  6. Quit Smoking: 1 person, 4.76%
  7. Progressive Multiple Sclerosis (chronic autoimmune disease of the central nervous system in which gradual destruction of myelin occurs in patches throughout the brain or spinal cord): 1 person, 4.76%
  8. Migraine (headache): 1 person, 4.76%
  9. Joint Pain: 1 person, 4.76%
  10. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Wellbutrin and have Idiopathic thrombocytopenic purpura?

Check whether Idiopathic thrombocytopenic purpura is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of Wellbutrin:

Idiopathic thrombocytopenic purpura treatments and more:

COVID vaccines that are related to Idiopathic thrombocytopenic purpura:

How severe was Idiopathic thrombocytopenic purpura and when was it recovered:

Expand to all the drugs that have ingredients of bupropion hydrochloride:

Common drugs associated with Idiopathic thrombocytopenic purpura:

All the drugs that are associated with Idiopathic thrombocytopenic purpura:

Common conditions associated with Idiopathic thrombocytopenic purpura:

All the conditions that are associated with Idiopathic thrombocytopenic purpura:

How the study uses the data?

The study uses data from the FDA. It is based on bupropion hydrochloride (the active ingredients of Wellbutrin) and Wellbutrin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: